Valerie Block on Muck Rack

Valerie Block

Verified
  • Journalist, Editor and Media Consultant, Freelance
New York
As seen in: MSN, CNBC, Yahoo Finance, SAGE Publishing, JAMA (The Journal of the American Medical Association), Ad Age, Barron's, WNBC-TV (New York, NY), KNBC-TV (Los Angeles, CA), KXAS-TV (Fort Worth, TX) and
Freelance editor and writer. I used to edit politics and business news @CNBC. Also former DME @CrainsNewYork. Birdwatching is my happy place 🦚
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Valerie

Contact Valerie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Landlords race to evolve offices for cachet and collaboration

|
By Valerie Block Verified
| Crain's New York Business Verified
By Valerie Block April 24, 2025 Employers still are trying to coax their teams back to the office on a full-time basis five years after the Covid 19 pandemic upended the way white collar employees work. But the methods are evolving. To attract talent, companies are seeking amenities from landlords that pre-Covid employees never dreamed of, like massive outdoor terraces, cafés and lounges, and purified air.
Open in Who Shared Issue with article?

New collar jobs are the wave of the future

|
By Valerie Block Verified
| Crain's New York Business Verified
The rise of artificial intelligence and automation is transforming the jobs landscape, making way for the growth of the "new collar" job. The term was coined in 2016 by then IBM CEO Ginni Rometty to characterize jobs geared to the digital economy. But the growth is just beginning. The jobs can be technically complex but do not necessarily require a four-year college degree.
Open in Who Shared Issue with article?

No evidence of fluctuations in daily step count between infusions in people with multiple sclerosis treated with anti-CD20 monoclonal antibodies

|
By Valerie Block Verified, Kyra Henderson, Shane T. Poole, Gabby B. Joseph
| SAGE Publishing
Summary Patients on some multiple sclerosis (MS) disease-modifying therapies (i.e., natalizumab) report a “self-reported wearing off” effect with increased symptoms before their infusion. This phenomenon lacks confirmation for anti-CD20 agents such as ocrelizumab and rituximab, via measurable MS worsening or patient-reported outcomes. A retrospective study analyzed Fitbit-monitored step counts (STEPS) in MS patients over 60 anti-CD20 therapy cycles.
Open in Who Shared Issue with article?
See all 89 licensed articles (106 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified